Cargando…

CD133-Positive Cells Might Be Responsible for Efficient Proliferation of Human Meningioma Cells

Owing to lack of appropriate model systems, investigations of meningioma biology have come to a stop. In this study, we developed a comprehensive digestion method and defined a culture system. Using this method and system, primary meningioma cells in conditioned suspension medium and a hypoxic envir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Hailiang, Gong, Ye, Mao, Ying, Xie, Qing, Zheng, Mingzhe, Wang, Daijun, Zhu, Hongda, Wang, Xuanchun, Chen, Hong, Chen, Xiancheng, Zhou, Liangfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382801/ https://www.ncbi.nlm.nih.gov/pubmed/22754374 http://dx.doi.org/10.3390/ijms13056424

Ejemplares similares

Analysis of Gene Expression Profiling in Meningioma: Deregulated Signaling Pathways Associated with Meningioma and EGFL6 Overexpression in Benign Meningioma Tissue and Serum
por: Wang, Xuanchun, et al.
Publicado: (2012)

The Diagnostic Value Of Using (18)F-Fluorodeoxyglucose Positron Emission Tomography To Differentiate Between Low- And High-Grade Meningioma
por: Hua, Lingyang, et al.
Publicado: (2019)

Role of CD133 in human embryonic stem cell proliferation and teratoma formation
por: Wang, Hua, et al.
Publicado: (2020)

CD133 (Prominin) Negative Human Neural Stem Cells Are Clonogenic and Tripotent
por: Sun, Yirui, et al.
Publicado: (2009)

The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations
por: Deng, Jiaojiao, et al.
Publicado: (2020)

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma
por: Wang, Daijun, et al.
Publicado: (2020)

Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma
por: Zhu, Hongda, et al.
Publicado: (2019)

FRAT1 Enhances the Proliferation and Tumorigenesis of CD133(+)Nestin(+) Glioma Stem Cells In Vitro and In Vivo
por: Guo, Geng, et al.
Publicado: (2020)

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma
por: Hua, Lingyang, et al.
Publicado: (2020)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications
por: Kelly, Sarah E., et al.
Publicado: (2010)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Chen, Shicai, et al.
Publicado: (2013)

The effect and molecular mechanism of hypoxia on proliferation and apoptosis of CD133(+) renal stem cells
por: Liu, Hong, et al.
Publicado: (2021)

Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells
por: Xue, Zhan-Xiong, et al.
Publicado: (2014)

Isolation and characteristics of CD133(−)/A2B5(+) and CD133(−)/A2B5(−) cells from the SHG139s cell line
por: HAN, YONG, et al.
Publicado: (2015)

Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity
por: Brown, Daniel V., et al.
Publicado: (2017)

Retraction: The effect and molecular mechanism of hypoxia on proliferation and apoptosis of CD133+ renal stem cells
Publicado: (2023)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

THE CD133-POSITIVE COLON CANCER CELL PHENOTYPE IS MORE INTERACTIVE WITH THE TUMOR MICROENVIRONMENT COMPARED TO CD133-NEGATIVE CELL
por: Chao, Celia, et al.
Publicado: (2011)

Low Concentrations of Metformin Selectively Inhibit CD133(+) Cell Proliferation in Pancreatic Cancer and Have Anticancer Action
por: Gou, Shanmiao, et al.
Publicado: (2013)

Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas
por: Sun, Shuchen, et al.
Publicado: (2022)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy
por: Deng, Jiaojiao, et al.
Publicado: (2021)

Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer
por: Zhou, Jin-Yong, et al.
Publicado: (2016)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

m(6)A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes
por: Chen, Jiawei, et al.
Publicado: (2021)

Prospectively Isolated Cancer-Associated CD10(+) Fibroblasts Have Stronger Interactions with CD133(+) Colon Cancer Cells than with CD133(−) Cancer Cells
por: Cui, Lin, et al.
Publicado: (2010)

CD133: a stem cell biomarker and beyond
por: Li, Zhong
Publicado: (2013)

Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma
por: ZHUANG, HUI-WEN, et al.
Publicado: (2013)

Prostate Cancer Stem Cells: The Role of CD133
por: Yang, Jianhui, et al.
Publicado: (2022)

Volume-activated chloride channel exists in CD133+ lung cancer stem cells
por: Mao, Z, et al.
Publicado: (2013)

Tropism of mesenchymal stem cell toward CD133(+) stem cell of glioblastoma in vitro and promote tumor proliferation in vivo
por: Pavon, Lorena Favaro, et al.
Publicado: (2018)

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133(+) osteosarcoma cancer stem cells
por: Ni, Miaozhong, et al.
Publicado: (2015)

Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma
por: Liu, Chao Lien, et al.
Publicado: (2020)

Overexpression of FES might inhibit cell proliferation, migration, and invasion of osteosarcoma cells
por: Zhao, Yang, et al.
Publicado: (2020)

CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation
por: Li, Chen, et al.
Publicado: (2016)

DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies
por: Cervantes-Madrid, Diana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sqa382ilots8fhdk3oldtce8mc